These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3552996)

  • 1. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
    Payne NR; Kim YK; Ferrieri P
    Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.
    Payne NR; Concepcion NF; Anthony BF
    Infect Immun; 1990 Nov; 58(11):3663-70. PubMed ID: 2228238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
    Baker CJ; Webb BJ; Kasper DL; Edwards MS
    J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.
    Payne NR; Ferrieri P
    J Infect Dis; 1985 Apr; 151(4):672-81. PubMed ID: 3882857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients.
    Pennie RA; Pearson RD; Barrett LJ; Lior H; Guerrant RL
    Infect Immun; 1986 Jun; 52(3):702-6. PubMed ID: 3710581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.
    Cleat PH; Coid CR
    Br J Exp Pathol; 1982 Aug; 63(4):452-7. PubMed ID: 6817779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of antibodies and complement in phagocytic killing of enterococci.
    Arduino RC; Murray BE; Rakita RM
    Infect Immun; 1994 Mar; 62(3):987-93. PubMed ID: 8112874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and antibody in neutrophil-mediated killing of type V group B streptococcus.
    Hall MA; Hickman ME; Baker CJ; Edwards MS
    J Infect Dis; 1994 Jul; 170(1):88-93. PubMed ID: 8014526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in the opsonic requirements of group B streptococcus type III.
    Hastings MJ; Easmon CS
    Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
    Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins.
    Rainard P; Lautrou Y; Poutrel B
    Vet Microbiol; 1988 Sep; 18(1):41-50. PubMed ID: 3055659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain specificity of opsonins for group B streptococci types II and III.
    Shigeoka AO; Hall RT; Hill HR
    Infect Immun; 1979 Feb; 23(2):438-45. PubMed ID: 370017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
    Levy NJ; Kasper DL
    Infect Immun; 1985 Jul; 49(1):19-24. PubMed ID: 3891622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.